多重用药对HIV感染者抗逆转录病毒处方的影响
该横断面分析基于Modena HIV代谢门诊队列2006至2015年2944例患者的电子数据,评估多重用药与抗逆转录病毒治疗方案(多片三联、单片方案或简化方案)的关系。多因素多项逻辑回归显示,多重用药与单片方案处方呈负相关(相对风险降低0.48,95%CI 0.28-0.81),校正衰弱等因素后仍独立相关;多片三联与简化方案间无此关联。
要点
- 多重用药的HIV感染者更少被处方单片方案(RRR=0.48,95%CI 0.28-0.81)。
- 多重用药与简化方案(单药或双药)处方无显著关联。
- 单片方案在多重合并症患者中可能因灵活性不足和药物相互作用风险而较少使用。
核心结论
- 多重用药与HIV感染者单片方案处方呈独立负相关,与简化方案无此关联。
主要发现
- 多项逻辑回归以多片三联为参照,多重用药与单片方案负相关(RRR=0.48,95%CI 0.28-0.81),校正衰弱(RRR=0.68,95%CI 0.59-0.78)、年龄、性别、HIV感染时长、当前及最低CD4和日历年。
- 多重用药与简化方案(单药或双药)处方无显著关联。
关键数值与推荐
- 多重用药定义为使用五种或以上药物(不包括抗逆转录病毒治疗)。
- 多合并症定义为存在两种或以上非感染性合并症。
临床怎么用
- 对多重用药的HIV感染者处方单片方案时,需评估药物相互作用和方案灵活性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the relationship between polypharmacy and ART, delivered as conventional multi-tablet three-drug regimens, single-tablet regimens or less-drug regimens (simplified mono or dual regimens). METHODS: We conducted a cross-sectional analysis of electronic data from the prospective Modena HIV Metabolic Clinic Cohort Study. We included the last clinical observation for each patient from January 2006 to December 2015. Polypharmacy was defined as the use of five or more medications (excluding ART). Multi-morbidity was classified as the presence of two or more non-infectious comorbidities. Factors associated with different ART regimens were analysed using multivariable multinomial logistic regression analyses with multi-tablet three-drug regimens as the reference. RESULTS: A total of 2944 patients (33.7% females) were included in the analysis. Multinomial logistic regression analysis identified polypharmacy to be negatively associated with single-tablet regimens [relative risk reduction (RRR) = 0.48, 95% CI = 0.28-0.81] independently from frailty (RRR = 0.68, 95% CI = 0.59-0.78), after correction for age, gender, HIV infection duration, current and nadir CD4 and calendar year. This association was not found comparing multi-tablet three-drug regimens and less-drug regimens. CONCLUSIONS: Single-tablet regimens are less likely to be prescribed in patients with polypharmacy. Single-tablet regimens are perceived to be less flexible in patients with multi-morbidity and at higher risk of drug-drug interaction.
引用
- Guaraldi G, Menozzi M, Zona S, et al. Impact of polypharmacy on antiretroviral prescription in people living with HIV. J Antimicrob Chemother. 2016. PMID: 27834193. doi:10.1093/jac/dkw437
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。